A17 peptide

Overview

A17 peptide is a Hsp70 -targeting peptide. A17 peptide binds to the ATP-binding domains of Hsp70 . A17 peptide specifically inhibits the chaperone activity, thereby increasing the cells' sensitivity to apoptosis induced by chemotherapeutic agents, such as Cisplatin ( HY-17394 ). A17 peptide can be used for anticancer chemotherapy research, such multiple myeloma.

Application

Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HSP

Product Information

• Catalog No.: HY-P11053
• CAS No.: 1140483-31-3
• Molecular Formula: C76H105N19O20S
• Molecular Weight: 1636.83
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source